BRIM Biotechnology, Inc. (TPE:6885)

Taiwan · Delayed Price · Currency is TWD

23.65

-0.30 (-1.25%)

At close: Mar 23, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
New Drug Translation and Development Services	5.49M	333.00K	90.00K	526.00K	360.00K
New Drug Translation and Development Services Growth	1548.65%	270.00%	-82.89%	46.11%	-99.60%
Total	5.49M	333.00K	90.00K	526.00K	360.00K
Total Growth	1548.65%	270.00%	-82.89%	46.11%	-99.60%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taiwan	5.49M	333.00K	90.00K	526.00K	360.00K
Taiwan Growth	1548.65%	270.00%	-82.89%	46.11%	-99.60%
Total	5.49M	333.00K	90.00K	526.00K	360.00K
Total Growth	1548.65%	270.00%	-82.89%	46.11%	-99.60%

Source: S&P Global Market Intelligence.